Integra LifeSciences (IART) - Net earnings per share (EPS TTM)
Regulatory challenges have temporarily weakened the pricing power of Integra LifeSciences (IART), as clearly demonstrated by the TTM EPS history. However, 0.16 shows the current value of the metric, confirming the resilience of this neurosurgery leader with unique tissue regeneration patents. Confidence in quality is further bolstered by the implementation of sustainable production standards and the optimization of raw material supply chains to minimize industrial waste.
IART (Integra LifeSciences Corp): analytical breakdowns and indicator data
- share price and expert price forecast:
- market capitalization indicators:
- business book valuation details:
- debt and liquidity details:
Debt to Equity Integra LifeSciences|IART - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Integra|IART - Company Cumulative Debt|Debts to Book Capitalization Integra LifeSciences Holdings Corporation|IART - Company Long-Term Indebtedness|Company Short-Term Debts Integra LifeSciences|Quick Ratio integralife.com
- net income and valuation multiples indicators:
IART - Net Income|Projected Future Earnings Integra LifeSciences|IART - P/E Multiple|Future Price to Earnings Integra LifeSciences Holdings Corporation|IART - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio Integra LifeSciences Holdings Corporation|IART - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Integra LifeSciences|IART - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months integralife.com|IART - Net earnings per share change in current year|Expected earnings per share growth for next year Integra LifeSciences
Basic company analysis:Integra LifeSciences (IART)
Net income per share over 12 months measures the equity resilience of the business, reflecting the actual yield of each security after adjusting the total financial result for the volume of issuance. Amid geopolitical supply disruptions and patent risks for Integra LifeSciences (IART), the current EPS TTM level allows for an assessment of the company's ability to generate profit despite logistical barriers, thereby determining the asset's fundamental value.
Direct competitors
BSX: Net earnings per share for the last 12 months|Earnings per one share for the last 12 months EW|RMD: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Insulet Corp (PODD)|ZBH (Zimmer Biomet Holdings) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months COO (CooperSurgical)|Net earnings per share for the last 12 months ALGN (Align Technology, Inc.)|GMED (globusmedical.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months TransMedics Group Inc TMDX|ATEC - Net earnings per share for the last 12 months|Artivion Inc - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Enovis Inc.|ESTA: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months BBNX|IRMD (IRADIMED) - Net earnings per share (EPS TTM)|Embecta Corp (EMBC) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) TNDM|Net earnings per share for the last 12 months Axogen Surgical AXGN|Net earnings per share (EPS TTM) SIBN (SI-BONE, Inc.)|Net earnings per share (EPS TTM) orthofix.com OFIX|BVS - Earnings per share for the last twelve months|KIDS: Earnings per share for the last twelve months|TMCI (Treace Medical) - Net earnings per share for the last 12 months|Strata Medical - Earnings per share for the trailing year|CARL (Carlsmed Inc) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months rxsight.com RXST|Earnings per share for the last twelve months ClearPoint Neuro, Inc. (CLPT)|Stereotaxis Inc (STXS) - Net earnings per share for the trailing year|NeuroStar - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Sight Sciences Inc SGHT|Orchestra BioMed, Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Anika Therapeutics ANIK|InspireMD (NSPR) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months ZJYL (Jin Medical)|Earnings per share for the last twelve months Vivani Medical Inc|Net earnings per share for the last 12 months Xtant Medical Inc (XTNT)|Net earnings per share (EPS TTM) NMTC|MODD - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Myomo MYO|COCH: Earnings per share for the last 12 months|VVOS: Net earnings per share for the last 12 months|enVVeno Corp - Earnings per share for the last four quarters|SINT: Net earnings per share (EPS TTM)|TNON - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Lifeward|Earnings per share for the last 12 months AMIX (Autonomix)|Net earnings per share for the last 12 months IVF (INVO Bioscience, Inc.)|Earnings per share for the last four quarters BBLG|Net earnings per share (EPS TTM) AXNX (Axonics, Inc.)|biolase.com (BIOL) - Net earnings per one share for the last twelve months|Dynatronics Corp. - Net earnings per share (EPS TTM)|Net earnings per share for the trailing year Paragon 28, Inc. (FNA)|invobioscience.com (INVO) - Earnings per share for the last twelve months
